衰弱与院内心脏骤停后长期生存、神经功能及患者报告结局是否相关?一项瑞典队列研究
该研究纳入2013-2021年卡罗林斯卡大学医院≥65岁院内心脏骤停患者,以临床衰弱量表(CFS)将病前状态分为非衰弱(1-4分)与衰弱(5-7分),评估长期生存、神经功能(CPC)及6个月电话随访的患者报告结局。817例符合条件患者中232例(28%)存活至30天,其中65例(28%)为衰弱。非衰弱者长期生存优于衰弱者:6个月生存92% vs 75%(P<0.01),3年生存74% vs 22%(P<0.01);非衰弱与衰弱者CPC从入院至出院保持不变的比例分别为87%与85%(P=0.52)。121例非衰弱者与27例衰弱者相比,EQ-VAS中位70分 vs 50分(P<0.01),抑郁症状16% vs 52%(P<0.01)。作者认为衰弱与长期生存显著下降、抑郁症状增加及总体健康更差相关。
要点
- ≥65岁院内心脏骤停30天存活者中衰弱占28%(65/232),衰弱者6个月生存75% vs 非衰弱92%(P<0.01)。
- 衰弱者3年生存仅22%,显著低于非衰弱者的74%(P<0.01)。
- 非衰弱与衰弱者出院时CPC较入院保持不变的比例分别为87%与85%(P=0.52)。
- 6个月随访时衰弱者EQ-VAS中位50分 vs 非衰弱70分(P<0.01),抑郁症状52% vs 16%(P<0.01)。
适用人群与场景
- 2013-2021年卡罗林斯卡大学医院≥65岁院内心脏骤停且存活至30天的患者。
诊断标准与关键阈值
- 病前衰弱采用临床衰弱量表(CFS)评估:非衰弱为1-4分,衰弱为5-7分。
研究设计与关键结果
- 研究类型为瑞典队列研究,纳入817例符合条件的≥65岁院内心脏骤停患者,其中232例(28%)存活至30天。
- 232例30天存活者中65例(28%)为衰弱;121例非衰弱者与27例衰弱者完成6个月电话随访。
- 长期生存:6个月生存非衰弱92% vs 衰弱75%(P<0.01);3年生存非衰弱74% vs 衰弱22%(P<0.01)。
- 神经功能:非衰弱与衰弱者CPC从入院至出院保持不变的比例分别为87%与85%(P=0.52)。
- 患者报告结局:EQ-VAS中位非衰弱70分 vs 衰弱50分(P<0.01);抑郁症状非衰弱16% vs 衰弱52%(P<0.01)。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为衰弱与院内心脏骤停后长期生存显著下降、抑郁症状增加及总体健康更差相关。
- 作者认为衰弱患者院内心脏骤停后存活者神经功能与入院时相同。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Frailty is associated with poor 30-days survival after in-hospital cardiac arrests (IHCA). The aim was to assess how pre-arrest frailty was associated with long-term survival, neurological function and patient-reported outcomes in elderly survivors after IHCA.
METHODS: Patients aged ≥ 65 years with IHCA at Karolinska University Hospital between 2013-2021 were studied. Frailty was assessed by the Clinical Frailty Scale (CFS) based on clinical records and categorised into non-frail (1-4) or frail (5-7). Survival was assessed in days. Neurological function was assessed by the Cerebral Performance Category scale (CPC). A telephone interview was performed six months post-IHCA and included the questionnaires EuroQoL-5 Dimensions-5 Levels and Hospital Anxiety and Depression Scale.
RESULTS: Totally, 232 (28%) out of 817 eligible patients survived to 30-days. Out of 232, 65 (28%) were frail. Long-term survival was better for non-frail than frail patients (6 months (92% versus 75%, p-value < 0.01), 3 years (74% vs 22%, p-value < 0.01)). The vast majority of both non-frail and frail patients had unchanged CPC from admittance to discharge from hospital (87% and 85%, respectively, p-value 0.52). The 121 non-frail patients reported better health compared to 27 frail patients (EQ-VAS median 70 versus 50 points, p-value < 0.01) and less symptoms of depression than frail (16% and 52%, respectively, p-value < 0.01).
CONCLUSION: Frail patients suffering IHCA survived with the same neurological function they had at admittance. Although one in five frail patients survived to three years, frailty was associated with a marked decrease in long-term survival as well as increased symptoms of depression and poorer general health.
参考来源
- Jonsson H, Piscator E, Israelsson J, et al. Is frailty associated with long-term survival, neurological function and patient-reported outcomes after in-hospital cardiac arrest? - A Swedish cohort study. Resuscitation. 2022. PMID: 35843406. doi:10.1016/j.resuscitation.2022.07.013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。